CoV-2 N-Mosaic

Coronavirus 2019 Nucleocapsid Mosaic Recombinant
Cat. No.
BT2032
Source
Escherichia Coli.
Synonyms
Appearance
Sterile Filtered clear solution.
Purity

CoV 2019 Nucleocapsid-Mosaic Protein ein is >90% pure as determined SDS-PAGE.

Usage
THE BioTek's products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
Shipped with Ice Packs
In Stock

Description

The E.Coli derived recombinant protein contains the Coronavirus 2019 full length nuclepocapsid Mosaic immunodominant regions [ full length N-antigen ], fused to 6xHis tag at C-terminal.

Product Specs

Introduction

The 2019 novel coronavirus (2019-nCoV), a human-infecting coronavirus causing viral pneumonia, emerged in a Wuhan, China seafood market in December 2019.

2019-nCoV shares 87% identity with the bat-derived SARS-CoV-2 found in Zhoushan, eastern China, in 2018. Despite amino acid variations, 2019-nCoV's receptor-binding domain (RBD) structure resembles that of 2018 SARS-CoV, suggesting potential binding to the human ACE2 receptor (angiotensin-converting enzyme 2).

While bats are suspected as the natural reservoir, an intermediate animal host from the seafood market is also suspected. Research suggests 2019-nCoV's spike glycoprotein is a recombinant of a bat coronavirus and an unknown coronavirus.

Description

This E. coli-derived recombinant protein consists of the full-length Coronavirus 2019 nucleocapsid protein with immunodominant regions (full-length N-antigen), fused to a C-terminal 6xHis tag.

Physical Appearance
A clear, sterile-filtered solution.
Formulation

The CoV 2019 Nucleocapsid-Mosaic protein solution is provided in 1x PBS (phosphate-buffered saline).

Stability

The CoV 2019 Nucleocapsid-Mosaic protein is shipped on ice packs. Upon receipt, store at -20°C.

Purity

The purity of the CoV 2019 Nucleocapsid-Mosaic protein is greater than 90% as determined by SDS-PAGE (sodium dodecyl-sulfate polyacrylamide gel electrophoresis).

Source
Escherichia Coli.
Specificity

Reactivity with SARS infected individuals not tested.

Product Science Overview

Introduction

The Coronavirus disease 2019 (COVID-19) pandemic, caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), has had a profound impact on global health and economies. The virus’s nucleocapsid (N) protein plays a crucial role in its life cycle and has become a focal point for vaccine and diagnostic development .

Structure and Function of the Nucleocapsid Protein

The SARS-CoV-2 nucleocapsid (N) protein is a multifunctional phosphoprotein essential for the virus’s replication and packaging of its RNA genome . It consists of two main domains: the N-terminal domain (NTD) and the C-terminal domain (CTD), connected by an intrinsically disordered region . The N protein is highly immunogenic and is the most abundant protein in the virion .

Role in the Viral Life Cycle

The N protein is involved in several critical activities post-virus invasion, including:

  • RNA Binding: The N protein binds to the viral RNA, facilitating its packaging into ribonucleoprotein complexes .
  • Transcription and Replication: It plays a role in the transcription and replication of the viral genome .
  • Virus Assembly: The N protein is essential for the assembly of new virus particles within the host cell .
Importance in Vaccine and Diagnostic Development

Due to its high immunogenicity and abundance, the N protein has been a target for developing vaccines and diagnostic tests . Recombinant forms of the N protein, such as the “Coronavirus 2019 Nucleocapsid Mosaic Recombinant,” have been engineered to enhance immune responses and improve diagnostic accuracy .

Structural Insights

Recent studies using cryo-electron microscopy and molecular modeling have provided new insights into the structural dynamics of the N protein. These studies have shown that the N protein can form higher-order oligomers, both in the presence and absence of RNA . Understanding these structural dynamics is crucial for developing strategies to inhibit virus assembly and improve therapeutic interventions .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.